IDO1 and neoplasm: If this is true in our experimental system, decreased expression of IDO1 in carbidopa-treated PDAC cells would reverse this process resulting in stimulation of mTORC1 signaling, which would be favorable for tumor growth, an effect opposite of what we observed.